Search PubMedSearch

Biomedical subjects

J W Hampton

Publications and source records attributed to J W Hampton.

At least 19 recordsLinked to original sources

Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.

Fifteen patients with recurrent squamous carcinoma of the head and neck received high-dose cytosine arabinoside (ara-C) (3 g/m2) and cisplatin (100 mg/m2) every 3 weeks in an attempt to explore the dose-dependent synergy between these two agents. A partial response was attained in one patient; there were no complete responses. The major toxicity was myelosuppression. With the current schedule, high-dose ara-C failed to improve the response rate achieved with cisplatin alone.

Adult

Enhancement of fibrinolysis in rabbits exposed to low and moderate levels of carbon monoxide inhibited by epsilon amino caproic acid.

The first (control) group of rabbits breathed ambient air whereas the second was exposed to low level carbon monoxide (CO, 50 ppm by volume) for 24 hr continuously for 8 weeks. The third group was exposed to 300 ppm CO for 4 weeks. The fourth group was exposed to 300 ppm CO for the same period of time as the third group but in addition they were also given epsilon amino caproic acid (EACA) orally, and the results compared to Group III. Per cent oxyhemoglobin (HbO2), per cent hemoglobin (Hb) and per cent carboxyhemoglobin (HbCO) were monitored in all groups. Tests of fibrinolysis were monitored and showed acceleration of the whole blood clot lysis and euglobulin lysis times (ELT). A fibrin plate test confirmed the increased lysis and serum fibrin and/or fibrinogen degradation products (FDP) were elevated in the CO exposed animals. No changes were observed in the same tests in the rabbits exposed to ambient air. The fourth group of animals receiving EACA showed inhibition of lysis and decrease in serum FDP. Alpha-1-antitrypsin and alpha-2-macroglobulin assays in all groups showed no change. Microscopic examination of the large vessels in these test groups showed endothelial damage which indicates a possible source for a plasminogen activator release, or lead to action of Hageman factor and activated plasma plasminogen proactivator.

Aminocaproates

The separation of S-carboxymethylated human fibrinogen chains with a single carboxymethyl-cellulose chromatography.

A single chromatography on CM 52 cellulose was sufficient to separate the S-carboxymethylated chains of human fibrinogen with a variable gradient mixer. The purity of the chains was confirmed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. Approximately 36 percent of the S-carboxymethylated fibrinogen was recovered as the purified chains.

Carboxymethylcellulose Sodium

Improved fibrin plate method for fibrinolytic activity measurements: use of bentonite precipitation and agar solidification.

A modification of the fibrin plate method to assure sterility and fibrin stability is described. Bovine fibrinogen is precipitated with bentonite to remove the plasminogen and agar is added to assure stability. Storage of the plates up to 7-10 days has resulted in no bacterial growth. This rapid, sensitive method is useful in the isolation of plasminogen or its activators by chromatographic separation.

Agar